Implantation of synthetic materials into the body elicits inflammatory host responses that limit medical device integration and biological performance. This inflammatory cascade involves protein adsorption, leukocyte recruitment and activation, cytokine release, and fibrous encapsulation of the implant. We present a coating strategy based on thin films of poly(N-isopropylacrylamide) hydrogel microparticles (i.e. microgels) cross-linked with poly(ethylene glycol) diacrylate. These particles were grafted onto a clinically relevant polymeric material to generate conformal coatings that significantly reduced in vitro fibrinogen adsorption and primary human monocyte/macrophage adhesion and spreading. These microgel coatings also reduced leukocyte adhesion and expression of pro-inflammatory cytokines (TNF-alpha, IL-1beta, MCP-1) in response to materials implanted acutely in the murine intraperitoneal space. These microgel coatings can be applied to biomedical implants as a protective coating to attenuate biofouling, leukocyte adhesion and activation, and adverse host responses for biomedical and biotechnological applications.
Implantation of synthetic materials into the body elicits inflammatory host responses that limit medical device integration and biological performance. This inflammatory cascade involves protein adsorption, leukocyte recruitment and activation, cytokine release, and fibrous encapsulation of the implant. We present a coating strategy based on thin films of poly(N-isopropylacrylamide) hydrogel microparticles (i.e. microgels) cross-linked with n class="Chemical">poly(ethylene glycol) diacrylate. These particles were grafted onto a clinically relevant polymeric material to generate conformal coatings that significantly reduced in vitro fibrinogen adsorption and primary human monocyte/macrophage adhesion and spreading. These microgel coatings also reduced leukocyte adhesion and expression of pro-inflammatory cytokines (TNF-alpha, IL-1beta, MCP-1) in response to materials implanted acutely in the murine intraperitoneal space. These microgel coatings can be applied to biomedical implants as a protective coating to attenuate biofouling, leukocyte adhesion and activation, and adverse host responses for biomedical and biotechnological applications.
Authors: Christine M Nolan; Catherine D Reyes; Justin D Debord; Andrés J García; L Andrew Lyon Journal: Biomacromolecules Date: 2005 Jul-Aug Impact factor: 6.988
Authors: W J van der Giessen; A M Lincoff; R S Schwartz; H M van Beusekom; P W Serruys; D R Holmes; S G Ellis; E J Topol Journal: Circulation Date: 1996-10-01 Impact factor: 29.690
Authors: Carl Neuerburg; Stefan Recknagel; Jörg Fiedler; Jürgen Groll; Martin Moeller; Kristina Bruellhoff; Heiko Reichel; Anita Ignatius; Rolf E Brenner Journal: J Mater Sci Mater Med Date: 2013-06-26 Impact factor: 3.896
Authors: Shalini Saxena; Mark W Spears; Hiroaki Yoshida; Jeffrey C Gaulding; Andrés J García; L Andrew Lyon Journal: Soft Matter Date: 2014-03-07 Impact factor: 3.679
Authors: Megan M Flake; Peter K Nguyen; Rebecca A Scott; Leah R Vandiver; Rebecca Kuntz Willits; Donald L Elbert Journal: Biomacromolecules Date: 2011-02-22 Impact factor: 6.988
Authors: Stacie M Gutowski; Kellie L Templeman; Antoinette B South; Jeffrey C Gaulding; James T Shoemaker; Michelle C LaPlaca; Ravi V Bellamkonda; L Andrew Lyon; Andrés J García Journal: J Biomed Mater Res A Date: 2013-06-25 Impact factor: 4.396